Literature DB >> 10582342

The transferrin receptor: role in health and disease.

P Ponka1, C N Lok.   

Abstract

The transferrin receptor is a membrane glycoprotein whose only clearly defined function is to mediate cellular uptake of iron from a plasma glycoprotein, transferrin. Iron uptake from transferrin involves the binding of transferrin to the transferrin receptor, internalization of transferrin within an endocytic vesicle by receptor-mediated endocytosis and the release of iron from the protein by a decrease in endosomal pH. With the exception of highly differentiated cells, transferrin receptors are probably expressed on all cells but their levels vary greatly. Transferrin receptors are highly expressed on immature erythroid cells, placental tissue, and rapidly dividing cells, both normal and malignant. In proliferating nonerythroid cells the expression of transferrin receptors is negatively regulated post-transcriptionally by intracellular iron through iron responsive elements (IREs) in the 3' untranslated region of transferrin receptor mRNA. IREs are recognized by specific cytoplasmic proteins (IRPs; iron regulatory proteins) that, in the absence of iron in the labile pool, bind to the IREs of transferrin receptor mRNA, preventing its degradation. On the other hand, the expansion of the labile iron pool leads to a rapid degradation of transferrin receptor mRNA that is not protected since IRPs are not bound to it. However, some cells and tissues with specific requirements for iron probably evolved mechanisms that can override the IRE/IRP-dependent control of transferrin receptor expression. Erythroid cells, which are the most avid consumers of iron in the organism, use a transcriptional mechanism to maintain very high transferrin receptor levels. Transcriptional regulation is also involved in the receptor expression during T and B lymphocyte activation. Macrophages are another example of a cell type that shows 'unorthodox' responses in terms of IRE/IRP paradigm since in these cells elevated iron levels increase (rather than decrease) transferrin receptor mRNA and protein levels. Erythroid cells contain the highest mass of the total organismal transferrin receptors which are released from reticulocytes during their maturation to erythrocytes. Hence, plasma contains small amounts of transferrin receptors which represent a soluble fragment of the extracellular receptor domain. Measurements of serum transferrin receptor concentrations are clinically useful since their levels correlate with the total mass of immature erythroid cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10582342     DOI: 10.1016/s1357-2725(99)00070-9

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  130 in total

1.  The role of 3'-untranslated region (3'-UTR) mediated mRNA stability in cardiovascular pathophysiology.

Authors:  C M Misquitta; V R Iyer; E S Werstiuk; A K Grover
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

Review 2.  MRNA stability and the control of gene expression: implications for human disease.

Authors:  Elysia M Hollams; Keith M Giles; Andrew M Thomson; Peter J Leedman
Journal:  Neurochem Res       Date:  2002-10       Impact factor: 3.996

3.  The haemochromatosis protein HFE induces an apparent iron-deficient phenotype in H1299 cells that is not corrected by co-expression of beta 2-microglobulin.

Authors:  Jian Wang; Guohua Chen; Kostas Pantopoulos
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

4.  Modulation of iron on mitochondrial aconitase expression in human prostatic carcinoma cells.

Authors:  Horng-Heng Juang
Journal:  Mol Cell Biochem       Date:  2004-10       Impact factor: 3.396

Review 5.  Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria.

Authors:  Dean P Jones; John J Lemasters; Derick Han; Urs A Boelsterli; Neil Kaplowitz
Journal:  Mol Interv       Date:  2010-04

6.  Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein.

Authors:  Yuanming Zhang; John C Rassa; Maria Elena deObaldia; Lorraine M Albritton; Susan R Ross
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Targeting of skeletal muscle in vitro using biotinylated immunoliposomes.

Authors:  Anita Schnyder; Stefan Krähenbühl; Michael Török; Jürgen Drewe; Jörg Huwyler
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

8.  Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection.

Authors:  Bruna Dos Santos Rodrigues; Hiroshi Oue; Amrita Banerjee; Takahisa Kanekiyo; Jagdish Singh
Journal:  J Control Release       Date:  2018-07-31       Impact factor: 9.776

9.  Endocytosis and intracellular trafficking properties of transferrin-conjugated block copolypeptide vesicles.

Authors:  Uh-Joo Choe; April R Rodriguez; Brian S Lee; Scott M Knowles; Anna M Wu; Timothy J Deming; Daniel T Kamei
Journal:  Biomacromolecules       Date:  2013-04-26       Impact factor: 6.988

10.  Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins.

Authors:  Dennis J Yoon; David S H Chu; Christopher W Ng; Edward A Pham; Anne B Mason; David M Hudson; Valerie C Smith; Ross T A MacGillivray; Daniel T Kamei
Journal:  J Control Release       Date:  2008-10-21       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.